Completed
A Study to Evaluate the Safety and Efficacy of PTC518 in Participants With Huntington's Disease (HD)
NCT05358717
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +17 more
- Locations
-
- University of California, San Diego La Jolla, California, United States
- Vanderbilt University Medical Center Nashville, Tennessee, United States
- The University of Texas Health Science Center at Houston; McGovern Medical School Houston, Texas, United States
- University of Washington Department of Neurology Seattle, Washington, United States